Impact of specific medical interventions on reducing the prevalence of mental retardation

被引:37
作者
Brosco, JP [1 ]
Mattingly, M [1 ]
Sanders, LM [1 ]
机构
[1] Univ Miami, Miller Sch Med, Dept Pediat, Miami, FL 33101 USA
来源
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE | 2006年 / 160卷 / 03期
关键词
D O I
10.1001/archpedi.160.3.302
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective: To explore the impact of medical interventions on reducing the prevalence of mental retardation (MR) in the United States over the last 50 years. Design: We reviewed the medical literature and other data from 1950 to 2000 to construct estimates of the general and condition-specific prevalence of MR in the United States over time. We further explored the existing literature to document historically important influences on condition-specific prevalence, including the year that an effective intervention was introduced, the likelihood of success of the intervention, and the availability of such interventions nationwide. Specific conditions included congenital syphilis, Rh hemolytic disease of the newborn, measles, Haemophilus influenzae type B meningitis, congenital hypothyroidism, phenylketonuria, and congenital rubella syndrome. Setting: Twentieth-century North America. Participants: Children with MR or 1 of the 7 specific conditions listed earlier. Main Outcome Measures: Case-specific and general prevalence of MR from 1950 to 2000. Results: The prevalence of MR caused by a number of specific medical conditions has decreased sharply over the last 50 years. However, the incidence of each of these conditions is relatively low, and cases of MR due to these conditions represent, at most, 16.5% of the total number of cases of MR in 1950. Conclusion: Although specific medical interventions have prevented thousands of cases of MR, their contribution to the overall prevalence of MR is relatively small.
引用
收藏
页码:302 / 309
页数:8
相关论文
共 93 条
  • [1] DECLINE OF CHILDHOOD HAEMOPHILUS-INFLUENZAE TYPE-B (HIB) DISEASE IN THE HIB VACCINE ERA
    ADAMS, WG
    DEAVER, KA
    COCHI, SL
    PLIKAYTIS, BD
    ZELL, ER
    BROOME, CV
    WENGER, JD
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (02): : 221 - 226
  • [2] Alexander D, 1998, MENT RETARD DEV D R, V4, P50, DOI 10.1002/(SICI)1098-2779(1998)4:1<50::AID-MRDD8>3.0.CO
  • [3] 2-0
  • [4] Efficacy of treatment for syphilis in pregnancy
    Alexander, JM
    Sheffield, JS
    Sanchez, PJ
    Mayfield, J
    Wendel, GD
    [J]. OBSTETRICS AND GYNECOLOGY, 1999, 93 (01) : 5 - 8
  • [5] American Association on Mental Retardation, 2002, MENT RET DEF CLASS S
  • [6] [Anonymous], 1985, J Pediatr, V107, P915
  • [7] [Anonymous], 1981, Lancet, V2, P1095
  • [8] Cognitive and neuropsychological outcomes: More than IQ scores
    Aylward, GP
    [J]. MENTAL RETARDATION AND DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS, 2002, 8 (04): : 234 - 240
  • [9] Immunization and the American way: 4 childhood vaccines
    Baker, JP
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 2000, 90 (02) : 199 - 207
  • [10] Behrman RichardE., 2004, NELSON TXB PEDIAT, V17th